IKT Financials

Inhibikase Therapeutics Inc - Financial statements & key metrics

Stock Price

$1.76

Market Cap

$225.78M

0

EPS

$-0.49

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

-

Gross Profit

-

Operating Income

-

Net Income

$-27.52M

EPS (Diluted)

$-1.16

Balance Sheet Highlights

Total Assets

$98.60M

Total Liabilities

$3.73M

Shareholders Equity

-

Cash & Equivalents

$56.50M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-19.15M

CapEx

-

Free Cash Flow

-

Profitability Metrics

Gross Margin

-3062780800.0%

ROE

-0.4%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is IKT revenue?

View IKT's income statement for detailed revenue data.

Is IKT profitable?

IKT reported a loss of $27.52M in the most recent quarter.

What is IKT market cap?

IKT has a market capitalization of $225.78M, making it a small-cap stock.

Does IKT have debt?

View IKT's balance sheet for debt information.

What is IKT cash flow?

Cash flow data is available in the full financial statements.

Explore Categories